AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through innovative bispecific antibodies, today announced that it will present a preclinical ...

Blocking the PROX1 protein allowed KAIST researchers to regenerate damaged retinas and restore vision in mice. Vision is one ...

In the first phase 3 trial to show the superiority of a TROP2-targeted antibody-drug conjugate and an immunotherapy agent in ...

In some patients with advanced triple-negative breast cancer, Trodelvy plus Keytruda was associated with an improvement in disease progression.

Pausing treatment during vaccination did not improve immunity in patients with chronic lymphocytic leukemia and should not be ...

Better diagnostics, more focused treatment, and deeper understanding of individualized symptoms could all take major steps ...

Single and multi-dose studies of the small molecule TREM2 agonist VG-3927 clear early safety hurdle. Meanwhile, new findings ...

Emerging biotech leader AKESF develops Ivonescimab & Cadonilimab; while offering growth potential with US partnerships, ...

More than 800 people in the U.S. have had measles since the beginning of the year, according to NBC News data. The majority ...

Amid the ongoing measles outbreak, many people might be wondering: do I need to get a measles vaccine booster?

Understanding allergies, from symptoms to treatment, genetics to environmental factors, and the likelihood of twins sharing ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...